Source: International Congress 2018 – New developments in tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
V. Gergert (Moscow, Russian Federation), A. Ergeshov (Moscow, Russian Federation), V. Yeremeev (Moscow, Russian Federation). Protective capacity of a new TB vaccine. 1960

Member's Comments

No comment yet.

Related content which might interest you: Towards a new vaccine for tuberculosis Source: Eur Respir Monogr 2018; 82: 343-363 Year: 2018 State of the art in vaccine development against TB Source: Eur Respir Mon 2012; 58: 59-71 Year: 2012 Mucosal immunity and novel vaccines against tuberculosis Source: Lung Science Conference 2015 Year: 2015 Additive preventive effect of influenza and pneumococcal vaccines in elderly persons Source: Eur Respir J 2004; 23: 363-368 Year: 2004 Assessment of BCG immunization effectiveness in children from TB infection sources Source: Annual Congress 2010 - Tuberculosis in children Year: 2010 Human immune recognition-based multicomponent subunit vaccines against tuberculosis Source: Eur Respir J 2005; 25: 902-910 Year: 2005 The protective effect of BCG vaccination against mycobacterium tuberculosis infection in children: A systematic review Source: International Congress 2014 – Tuberculosis: public health and primary prevention Year: 2014 The case for assessing the full value of new tuberculosis vaccines Source: Eur Respir J, 55 (3) 1902414; 10.1183/13993003.02414-2019 Year: 2020 Influence of vaccine prevention of pneumoccocus conjugated vaccine on mortality in patients with COPD Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Prime-boost, double-dose immunization and immunity to influenza vaccination in COPD Source: Virtual Congress 2021 – Pneumonia Year: 2021 Efficacy of vaccination to prevent pneumococcal infection in organized communities Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 Immunogenicity and safety of a novel recombinant pandemic influenza vaccine containing a polysaccharide adjuvant Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects Year: 2010 Does BCG revaccination lead to enhanced protective immunity against tuberculosis? A study using surrogate markers Source: Annual Congress 2005 - Epidemiology and control of tuberculosis and LTBI Year: 2005 Previous pneumococcal polysaccharide vaccine impacts immune response to subsequent pneumococcal conjugate vaccine in the elderly Source: Eur Respir J 2005; 26: Suppl. 49, 673s Year: 2005 Protective efficacy and antigenicity of influenza HA-VLPs in a murine model of postinfluenza bacterial pneumonia. Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019 Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects Source: Eur Respir J 2005; 26: 1086-1091 Year: 2005